4
Changes in Ownership
UNITED THERAPEUTICS Corp Filed Acc 0001106578-26-000101
Chairperson & CEO sold 9,500 shares at an average $537.05 ($5,101,939)
- Chairperson & CEO acquired 9,500 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
ROTHBLATT MARTINE A · Chairperson & CEO
Table I: Non-derivative
12 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-07-17 | Exercise or conversion : show line 1 in the form 10b5-1 | +9,500 | $135.42 | $1,286,490 | 333,943 | I |
| 2026-07-17 | Sale : show line 2 in the form 10b5-1 | −240 | $528.91 | $126,938 | 333,703 | I |
| 2026-07-17 | Sale : show line 3 in the form 10b5-1 | −240 | $530.83 | $127,400 | 333,463 | I |
| 2026-07-17 | Sale : show line 4 in the form 10b5-1 | −720 | $534.57 | $384,889 | 332,743 | I |
| 2026-07-17 | Sale : show line 5 in the form 10b5-1 | −2,350 | $535.53 | $1,258,486 | 330,393 | I |
| 2026-07-17 | Sale : show line 6 in the form 10b5-1 | −2,110 | $536.36 | $1,131,717 | 328,283 | I |
| 2026-07-17 | Sale : show line 7 in the form 10b5-1 | −1,160 | $537.45 | $623,438 | 327,123 | I |
| 2026-07-17 | Sale : show line 8 in the form 10b5-1 | −423 | $538.70 | $227,871 | 326,700 | I |
| Open-market sales · 9,500 sh · avg $537.05 · $5,101,939 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-07-17 | Exercise or conversion : show line 13 in the form 10b5-1 Stock Option | −9,500 | 322,410 | I |
Loading xslF345X06/primarydocument.xml…